1AD
ADALTA LIMITED
$0.0030
0.00%
Market cap
$10M
Turnover
$2,439
Last price
$0.0030
Day change
0.00%
Announcements
20
Range, past year
Open 0.002 · Low 0.002 · Now 0.003 · High 0.008
Open 1AD in the full dashboard →
Charts, screener, momentum and signals across every ASX-listed code.
1AD momentum and trend analysis
Our analysis
Independent analysis generated by Stock Trade Intelligence
as at 2026-09-28.
Momentum quality
18/100
Wyckoff phase
Accumulation38d
Trend stage
Neutral
1 Day
+0.0%
1 Week
+0.0%
1 Month
+0.0%
1 Year
+50.0%
RSI
46
Avg daily range
24.6%
ADALTA LIMITED scores 18 out of 100 for momentum quality, a reading rated very low confidence. The score weighs trend structure, price consistency, volume backing and how long the move has held, so a high reading means a sustained trend rather than a single large day. Its trend is currently classified as Neutral.
On the Wyckoff cycle it sits in Accumulation, where it has been for 38 trading days. The weekly timeframe reads Downtrend, which does not yet agree with the daily view.
Against the wider market it is currently matching and the institutional accumulation signal reads low.
Points to watch
- 60d drawdown -25.0%
- High volatility (ATR 24.6%)
- Thin liquidity
- Risk rating: Very High
- Composite downside risk elevated
1AD announcements
Recent price-sensitive releases.
- 2026-09-23 US FDA grants EW-001 pre-IND meeting Progress Report
- 2026-09-18 Oribiotech deal validates AdAlta manufacturing strategy Progress Report
- 2026-09-02 BZDS1901 special access scheme launch in China Progress Report
- 2026-08-21 Preliminary Final Report Preliminary Final Report
- 2026-08-10 EW-001 IIT study overall survival update Progress Report
- 2026-08-05 2 year survival milestone for EW-001 patient Progress Report
- 2026-07-29 Quarterly Appendix 4C and Activities Report Commitments Test Entity - Fourth Quarter Activity Report | Commitments Test Entity - Fourth Quarter Cashflow Report
More Health Care stocks
Most traded in the same sector.